These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2051022)

  • 1. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor.
    Lamas AM; Leon OG; Schleimer RP
    J Immunol; 1991 Jul; 147(1):254-9. PubMed ID: 2051022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids inhibit cytokine-mediated eosinophil survival.
    Wallen N; Kita H; Weiler D; Gleich GJ
    J Immunol; 1991 Nov; 147(10):3490-5. PubMed ID: 1940348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils.
    Hallsworth MP; Litchfield TM; Lee TH
    Immunology; 1992 Feb; 75(2):382-5. PubMed ID: 1551701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human endothelial cells prolong eosinophil survival. Regulation by cytokines and glucocorticoids.
    Lamas AM; Marcotte GV; Schleimer RP
    J Immunol; 1989 Jun; 142(11):3978-84. PubMed ID: 2654295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions.
    Robinson AJ; Kashanin D; O'Dowd F; Fitzgerald K; Williams V; Walsh GM
    Clin Exp Allergy; 2009 Dec; 39(12):1866-74. PubMed ID: 19689459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines.
    Ebisawa M; Liu MC; Yamada T; Kato M; Lichtenstein LM; Bochner BS; Schleimer RP
    J Immunol; 1994 May; 152(9):4590-6. PubMed ID: 8157972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor.
    Levi-Schaffer F; Temkin V; Malamud V; Feld S; Zilberman Y
    J Immunol; 1998 Jun; 160(11):5554-62. PubMed ID: 9605160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium.
    Her E; Frazer J; Austen KF; Owen WF
    J Clin Invest; 1991 Dec; 88(6):1982-7. PubMed ID: 1752957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin.
    Walsh GM; Wardlaw AJ
    J Allergy Clin Immunol; 1997 Aug; 100(2):208-15. PubMed ID: 9275142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinase-activated receptor 2.
    Vliagoftis H; Befus AD; Hollenberg MD; Moqbel R
    J Allergy Clin Immunol; 2001 Apr; 107(4):679-85. PubMed ID: 11295658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor.
    Tomioka K; MacGlashan DW; Lichtenstein LM; Bochner BS; Schleimer RP
    J Immunol; 1993 Nov; 151(9):4989-97. PubMed ID: 8409452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils.
    Okada S; Hagan JB; Kato M; Bankers-Fulbright JL; Hunt LW; Gleich GJ; Kita H
    J Immunol; 1998 Apr; 160(8):4010-7. PubMed ID: 9558110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil activation in the tissue: synthetic steroid, budesonide, effectively inhibits the survival of eosinophils isolated from peripheral blood but not nasal polyp tissues.
    Nonaka R; Nonaka M; Takanashi S; Jordana M; Dolovich J
    J Clin Lab Immunol; 1999; 51(1):39-53. PubMed ID: 11424740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival.
    Sedgwick JB; Busse WW
    Ann Allergy Asthma Immunol; 1997 Jun; 78(6):581-5. PubMed ID: 9207722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone.
    Hartnell A; Kay AB; Wardlaw AJ
    Immunology; 1992 Dec; 77(4):488-93. PubMed ID: 1493920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis.
    Sale R; Sabatini F; Silvestri M; Serpero L; Petecchia L; Rossi GA
    Int Immunopharmacol; 2004 Dec; 4(13):1687-96. PubMed ID: 15454120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of eosinophil survival by epinastine hydrochloride, an H1 receptor antagonist, in vitro.
    Watase F; Watanabe S; Kanai K; Yamada N; Sakaue S; Asano K; Hisamitsu T; Suzaki H
    In Vivo; 2008; 22(6):687-91. PubMed ID: 19180992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
    Solomon A; Shmilowich R; Shasha D; Frucht-Pery J; Pe'er J; Bonini S; Levi-Schaffer F
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1038-44. PubMed ID: 10752939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT(1)R antagonism.
    Robinson AJ; Kashanin D; O'Dowd F; Williams V; Walsh GM
    J Leukoc Biol; 2008 Jun; 83(6):1522-9. PubMed ID: 18332235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.